Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05858879 · ClinicalTrials.gov registry record · NA

Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)

A NA study of ASCVD and Coronary Artery Calcification, sponsored by Stanford University.

Active
Registry status
NA
Development phase
233
Enrollment target
1
Study location

NCT05858879 is a NA study of ASCVD and Coronary Artery Calcification that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 233 participants, below the 13,405-participant average among 5 other ASCVD trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05858879, a NA study of ASCVD and Coronary Artery Calcification, is active but no longer recruiting, sponsored by Stanford University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
233 participants
Enrollment target
1
Study location

Study Summary

Estimate the impact of notifying both patients and their clinicians of the presence of incidental coronary artery calcium (CAC) on initiation of lipid-lowering therapy in patients with ASCVD who are not receiving lipid-lowering therapy.

Conditions Studied

ASCVD Coronary Artery Calcification

Interventions

  • OTHER Notification of patients and clinicians

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 233 participants
Start Date 2024-10-22
Est. Completion 2026-09
Phase NA

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05858879

The ClinicalTrials.gov registry entry for NCT05858879 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 233 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,405-participant average among 5 other ASCVD trials with a reported enrollment target (98% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with ASCVD appearing as the primary indexed condition, and to 1 intervention - of which Notification of patients and clinicians is the first listed.

NCT05858879 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05858879 about?

NCT05858879 is a clinical study titled "Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)". Estimate the impact of notifying both patients and their clinicians of the presence of incidental coronary artery calcium (CAC) on initiation of lipid-lowering therapy in patients with ASCVD who are not receiving lipid-lowering therapy.

What is the current status of trial NCT05858879?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 233 participants. The study started on 2024-10-22. Estimated completion is 2026-09.

What conditions does trial NCT05858879 study?

This clinical trial studies the following conditions: ASCVD, Coronary Artery Calcification.

What interventions are being tested in trial NCT05858879?

The interventions under investigation include: Notification of patients and clinicians (OTHER).

Who is sponsoring clinical trial NCT05858879?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05858879 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for ASCVD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

ASCVD

All registered trials for this condition

Coronary Artery Calcification

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.